Summary

The global Preeclampsia Laboratory Testing Market is poised for substantial growth, with a projected valuation of USD 1.4 billion in 2026, expected to reach USD 2.3 billion by 2033, growing at a compound annual growth rate (CAGR) of 8.0% during the forecast period. Increasing awareness of maternal health complications, coupled with advancements in laboratory diagnostics, is set to drive the adoption of preeclampsia testing across healthcare settings worldwide.



Market Insights



Preeclampsia, a hypertensive disorder occurring during pregnancy, remains a significant contributor to maternal and neonatal morbidity and mortality. Early detection through reliable laboratory testing plays a crucial role in managing the condition and preventing severe complications such as eclampsia, organ damage, and preterm birth. The market is witnessing increasing emphasis on both urine and blood-based diagnostic assays, which help clinicians assess the severity of the disease and guide timely interventions.



Innovations in diagnostic technologies, including metabolomics-based biomarkers and immunoassays, are further enhancing the accuracy and efficiency of preeclampsia detection. Coupled with rising prenatal screening initiatives, these technological advancements are enabling healthcare providers to offer personalized care for at-risk pregnant women.



Market Drivers



The growth of the Preeclampsia Laboratory Testing Market is fueled by several key factors:



1. Rising Maternal Health Awareness: Governments and NGOs worldwide are advocating for routine prenatal screenings, including preeclampsia testing, to reduce maternal mortality rates. This has led to increased demand for reliable laboratory diagnostics.



2. Technological Advancements: The development of highly sensitive blood and urine tests, incorporating biomarkers for early detection, has made preeclampsia diagnostics more accessible and precise.



3. Growing Prevalence of Hypertensive Disorders in Pregnancy: Epidemiological studies indicate an increasing incidence of preeclampsia, particularly in urban populations, which drives demand for laboratory testing.



4. Supportive Government Policies and Funding: Investment in maternal healthcare infrastructure and prenatal care programs is encouraging healthcare providers to adopt advanced diagnostic tools for early disease detection.



5. Integration with Personalized Medicine: Laboratories are leveraging novel biomarkers to customize monitoring and intervention strategies, enhancing the overall care pathway for pregnant women.



Business Opportunities



The market offers extensive opportunities for diagnostic manufacturers and healthcare providers. Key business prospects include:



• Expansion in Emerging Economies: Growing prenatal care programs in regions like Asia Pacific and Latin America present a significant growth avenue for laboratory test manufacturers.



• Product Portfolio Diversification: Companies can capitalize on developing both urine- and blood-based diagnostic solutions tailored to different preeclampsia severities.



• Strategic Collaborations and Partnerships: Partnerships between diagnostics companies and hospitals or prenatal clinics can enhance market reach and streamline adoption of innovative tests.



• Investment in R&D: Continuous research into predictive biomarkers and point-of-care diagnostic solutions can offer a competitive advantage in the market.



Regional Analysis



North America dominates the market owing to well-established healthcare infrastructure, widespread awareness of maternal health issues, and extensive research initiatives. The region also benefits from high adoption of technologically advanced laboratory diagnostics.



Europe follows closely, supported by robust prenatal care programs and government-led initiatives promoting early disease detection.



The Asia Pacific market is expected to witness the fastest growth due to increasing healthcare expenditure, expanding prenatal care coverage, and rising awareness of maternal complications among pregnant women.



Latin America and the Middle East & Africa are anticipated to see moderate growth, driven by gradual improvements in healthcare infrastructure and increasing focus on maternal health by public and private stakeholders.



Key Players



The global preeclampsia laboratory testing market is highly competitive, with several prominent companies leading product development and market expansion initiatives. Key players include:



• DiabetOmics



• DRG Instruments GmbH



• Hoffmann-La Roche Ltd.



• GestVision, Inc.



• Lifeassay Diagnostics (Pty) Ltd.



• Metabolomic Diagnostics



• Perkin Elmer, Inc.



• Progenity, Inc.



• Quidel Corporation



• Siemens Healthineers



• Thermo Fisher Scientific, Inc.



These companies are focusing on innovative diagnostic platforms, strategic collaborations, and expansion into emerging regions to strengthen their market presence.



Market Segmentation



The Preeclampsia Laboratory Testing Market can be segmented based on test type, preeclampsia type, end user, and geographic coverage:



By Test Type



• Urine Tests



• Blood Tests



By Preeclampsia Type



• Mild Preeclampsia



• Severe Preeclampsia



By End User



• Hospitals and Clinics



• Diagnostic Centres



• Others



By Geographic Coverage



• North America



• Europe



• Asia Pacific



• Latin America



• Middle East and Africa

ページTOPに戻る

Table of Contents

1. Executive Summary
1.1. Global Preeclampsia Laboratory Testing Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2026
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. COVID-19 Impact Analysis
2.5. Porter's Fiver Forces Analysis
2.6. Impact of Russia-Ukraine Conflict
2.7. PESTLE Analysis
2.8. Regulatory Analysis
2.9. Price Trend Analysis
2.9.1. Current Prices and Future Projections, 2025-2033
2.9.2. Price Impact Factors
3. Global Preeclampsia Laboratory Testing Market Outlook, 2020-2033
3.1. Global Preeclampsia Laboratory Testing Market Outlook, by Test Type, Value (US$ Bn), 2020-2033
3.1.1. Urine Tests
3.1.2. Blood Tests
3.2. Global Preeclampsia Laboratory Testing Market Outlook, by Preeclampsia Type, Value (US$ Bn), 2020-2033
3.2.1. Mild Preeclampsia
3.2.2. Severe Preeclampsia
3.3. Global Preeclampsia Laboratory Testing Market Outlook, by End User, Value (US$ Bn), 2020-2033
3.3.1. Hospitals and Clinics
3.3.2. Diagnostic Centres
3.4. Global Preeclampsia Laboratory Testing Market Outlook, by Region, Value (US$ Bn), 2020-2033
3.4.1. North America
3.4.2. Europe
3.4.3. Asia Pacific
3.4.4. Latin America
3.4.5. Middle East & Africa
4. North America Preeclampsia Laboratory Testing Market Outlook, 2020-2033
4.1. North America Preeclampsia Laboratory Testing Market Outlook, by Test Type, Value (US$ Bn), 2020-2033
4.1.1. Urine Tests
4.1.2. Blood Tests
4.2. North America Preeclampsia Laboratory Testing Market Outlook, by Preeclampsia Type, Value (US$ Bn), 2020-2033
4.2.1. Mild Preeclampsia
4.2.2. Severe Preeclampsia
4.3. North America Preeclampsia Laboratory Testing Market Outlook, by End User, Value (US$ Bn), 2020-2033
4.3.1. Hospitals and Clinics
4.3.2. Diagnostic Centres
4.4. North America Preeclampsia Laboratory Testing Market Outlook, by Country, Value (US$ Bn), 2020-2033
4.4.1. U.S. Preeclampsia Laboratory Testing Market Outlook, by Test Type, 2020-2033
4.4.2. U.S. Preeclampsia Laboratory Testing Market Outlook, by Preeclampsia Type, 2020-2033
4.4.3. U.S. Preeclampsia Laboratory Testing Market Outlook, by End User, 2020-2033
4.4.4. Canada Preeclampsia Laboratory Testing Market Outlook, by Test Type, 2020-2033
4.4.5. Canada Preeclampsia Laboratory Testing Market Outlook, by Preeclampsia Type, 2020-2033
4.4.6. Canada Preeclampsia Laboratory Testing Market Outlook, by End User, 2020-2033
4.5. BPS Analysis/Market Attractiveness Analysis
5. Europe Preeclampsia Laboratory Testing Market Outlook, 2020-2033
5.1. Europe Preeclampsia Laboratory Testing Market Outlook, by Test Type, Value (US$ Bn), 2020-2033
5.1.1. Urine Tests
5.1.2. Blood Tests
5.2. Europe Preeclampsia Laboratory Testing Market Outlook, by Preeclampsia Type, Value (US$ Bn), 2020-2033
5.2.1. Mild Preeclampsia
5.2.2. Severe Preeclampsia
5.3. Europe Preeclampsia Laboratory Testing Market Outlook, by End User, Value (US$ Bn), 2020-2033
5.3.1. Hospitals and Clinics
5.3.2. Diagnostic Centres
5.4. Europe Preeclampsia Laboratory Testing Market Outlook, by Country, Value (US$ Bn), 2020-2033
5.4.1. Germany Preeclampsia Laboratory Testing Market Outlook, by Test Type, 2020-2033
5.4.2. Germany Preeclampsia Laboratory Testing Market Outlook, by Preeclampsia Type, 2020-2033
5.4.3. Germany Preeclampsia Laboratory Testing Market Outlook, by End User, 2020-2033
5.4.4. Italy Preeclampsia Laboratory Testing Market Outlook, by Test Type, 2020-2033
5.4.5. Italy Preeclampsia Laboratory Testing Market Outlook, by Preeclampsia Type, 2020-2033
5.4.6. Italy Preeclampsia Laboratory Testing Market Outlook, by End User, 2020-2033
5.4.7. France Preeclampsia Laboratory Testing Market Outlook, by Test Type, 2020-2033
5.4.8. France Preeclampsia Laboratory Testing Market Outlook, by Preeclampsia Type, 2020-2033
5.4.9. France Preeclampsia Laboratory Testing Market Outlook, by End User, 2020-2033
5.4.10. U.K. Preeclampsia Laboratory Testing Market Outlook, by Test Type, 2020-2033
5.4.11. U.K. Preeclampsia Laboratory Testing Market Outlook, by Preeclampsia Type, 2020-2033
5.4.12. U.K. Preeclampsia Laboratory Testing Market Outlook, by End User, 2020-2033
5.4.13. Spain Preeclampsia Laboratory Testing Market Outlook, by Test Type, 2020-2033
5.4.14. Spain Preeclampsia Laboratory Testing Market Outlook, by Preeclampsia Type, 2020-2033
5.4.15. Spain Preeclampsia Laboratory Testing Market Outlook, by End User, 2020-2033
5.4.16. Russia Preeclampsia Laboratory Testing Market Outlook, by Test Type, 2020-2033
5.4.17. Russia Preeclampsia Laboratory Testing Market Outlook, by Preeclampsia Type, 2020-2033
5.4.18. Russia Preeclampsia Laboratory Testing Market Outlook, by End User, 2020-2033
5.4.19. Rest of Europe Preeclampsia Laboratory Testing Market Outlook, by Test Type, 2020-2033
5.4.20. Rest of Europe Preeclampsia Laboratory Testing Market Outlook, by Preeclampsia Type, 2020-2033
5.4.21. Rest of Europe Preeclampsia Laboratory Testing Market Outlook, by End User, 2020-2033
5.5. BPS Analysis/Market Attractiveness Analysis
6. Asia Pacific Preeclampsia Laboratory Testing Market Outlook, 2020-2033
6.1. Asia Pacific Preeclampsia Laboratory Testing Market Outlook, by Test Type, Value (US$ Bn), 2020-2033
6.1.1. Urine Tests
6.1.2. Blood Tests
6.2. Asia Pacific Preeclampsia Laboratory Testing Market Outlook, by Preeclampsia Type, Value (US$ Bn), 2020-2033
6.2.1. Mild Preeclampsia
6.2.2. Severe Preeclampsia
6.3. Asia Pacific Preeclampsia Laboratory Testing Market Outlook, by End User, Value (US$ Bn), 2020-2033
6.3.1. Hospitals and Clinics
6.3.2. Diagnostic Centres
6.4. Asia Pacific Preeclampsia Laboratory Testing Market Outlook, by Country, Value (US$ Bn), 2020-2033
6.4.1. China Preeclampsia Laboratory Testing Market Outlook, by Test Type, 2020-2033
6.4.2. China Preeclampsia Laboratory Testing Market Outlook, by Preeclampsia Type, 2020-2033
6.4.3. China Preeclampsia Laboratory Testing Market Outlook, by End User, 2020-2033
6.4.4. Japan Preeclampsia Laboratory Testing Market Outlook, by Test Type, 2020-2033
6.4.5. Japan Preeclampsia Laboratory Testing Market Outlook, by Preeclampsia Type, 2020-2033
6.4.6. Japan Preeclampsia Laboratory Testing Market Outlook, by End User, 2020-2033
6.4.7. South Korea Preeclampsia Laboratory Testing Market Outlook, by Test Type, 2020-2033
6.4.8. South Korea Preeclampsia Laboratory Testing Market Outlook, by Preeclampsia Type, 2020-2033
6.4.9. South Korea Preeclampsia Laboratory Testing Market Outlook, by End User, 2020-2033
6.4.10. India Preeclampsia Laboratory Testing Market Outlook, by Test Type, 2020-2033
6.4.11. India Preeclampsia Laboratory Testing Market Outlook, by Preeclampsia Type, 2020-2033
6.4.12. India Preeclampsia Laboratory Testing Market Outlook, by End User, 2020-2033
6.4.13. Southeast Asia Preeclampsia Laboratory Testing Market Outlook, by Test Type, 2020-2033
6.4.14. Southeast Asia Preeclampsia Laboratory Testing Market Outlook, by Preeclampsia Type, 2020-2033
6.4.15. Southeast Asia Preeclampsia Laboratory Testing Market Outlook, by End User, 2020-2033
6.4.16. Rest of SAO Preeclampsia Laboratory Testing Market Outlook, by Test Type, 2020-2033
6.4.17. Rest of SAO Preeclampsia Laboratory Testing Market Outlook, by Preeclampsia Type, 2020-2033
6.4.18. Rest of SAO Preeclampsia Laboratory Testing Market Outlook, by End User, 2020-2033
6.5. BPS Analysis/Market Attractiveness Analysis
7. Latin America Preeclampsia Laboratory Testing Market Outlook, 2020-2033
7.1. Latin America Preeclampsia Laboratory Testing Market Outlook, by Test Type, Value (US$ Bn), 2020-2033
7.1.1. Urine Tests
7.1.2. Blood Tests
7.2. Latin America Preeclampsia Laboratory Testing Market Outlook, by Preeclampsia Type, Value (US$ Bn), 2020-2033
7.2.1. Mild Preeclampsia
7.2.2. Severe Preeclampsia
7.3. Latin America Preeclampsia Laboratory Testing Market Outlook, by End User, Value (US$ Bn), 2020-2033
7.3.1. Hospitals and Clinics
7.3.2. Diagnostic Centres
7.4. Latin America Preeclampsia Laboratory Testing Market Outlook, by Country, Value (US$ Bn), 2020-2033
7.4.1. Brazil Preeclampsia Laboratory Testing Market Outlook, by Test Type, 2020-2033
7.4.2. Brazil Preeclampsia Laboratory Testing Market Outlook, by Preeclampsia Type, 2020-2033
7.4.3. Brazil Preeclampsia Laboratory Testing Market Outlook, by End User, 2020-2033
7.4.4. Mexico Preeclampsia Laboratory Testing Market Outlook, by Test Type, 2020-2033
7.4.5. Mexico Preeclampsia Laboratory Testing Market Outlook, by Preeclampsia Type, 2020-2033
7.4.6. Mexico Preeclampsia Laboratory Testing Market Outlook, by End User, 2020-2033
7.4.7. Argentina Preeclampsia Laboratory Testing Market Outlook, by Test Type, 2020-2033
7.4.8. Argentina Preeclampsia Laboratory Testing Market Outlook, by Preeclampsia Type, 2020-2033
7.4.9. Argentina Preeclampsia Laboratory Testing Market Outlook, by End User, 2020-2033
7.4.10. Rest of LATAM Preeclampsia Laboratory Testing Market Outlook, by Test Type, 2020-2033
7.4.11. Rest of LATAM Preeclampsia Laboratory Testing Market Outlook, by Preeclampsia Type, 2020-2033
7.4.12. Rest of LATAM Preeclampsia Laboratory Testing Market Outlook, by End User, 2020-2033
7.5. BPS Analysis/Market Attractiveness Analysis
8. Middle East & Africa Preeclampsia Laboratory Testing Market Outlook, 2020-2033
8.1. Middle East & Africa Preeclampsia Laboratory Testing Market Outlook, by Test Type, Value (US$ Bn), 2020-2033
8.1.1. Urine Tests
8.1.2. Blood Tests
8.2. Middle East & Africa Preeclampsia Laboratory Testing Market Outlook, by Preeclampsia Type, Value (US$ Bn), 2020-2033
8.2.1. Mild Preeclampsia
8.2.2. Severe Preeclampsia
8.3. Middle East & Africa Preeclampsia Laboratory Testing Market Outlook, by End User, Value (US$ Bn), 2020-2033
8.3.1. Hospitals and Clinics
8.3.2. Diagnostic Centres
8.4. Middle East & Africa Preeclampsia Laboratory Testing Market Outlook, by Country, Value (US$ Bn), 2020-2033
8.4.1. GCC Preeclampsia Laboratory Testing Market Outlook, by Test Type, 2020-2033
8.4.2. GCC Preeclampsia Laboratory Testing Market Outlook, by Preeclampsia Type, 2020-2033
8.4.3. GCC Preeclampsia Laboratory Testing Market Outlook, by End User, 2020-2033
8.4.4. South Africa Preeclampsia Laboratory Testing Market Outlook, by Test Type, 2020-2033
8.4.5. South Africa Preeclampsia Laboratory Testing Market Outlook, by Preeclampsia Type, 2020-2033
8.4.6. South Africa Preeclampsia Laboratory Testing Market Outlook, by End User, 2020-2033
8.4.7. Egypt Preeclampsia Laboratory Testing Market Outlook, by Test Type, 2020-2033
8.4.8. Egypt Preeclampsia Laboratory Testing Market Outlook, by Preeclampsia Type, 2020-2033
8.4.9. Egypt Preeclampsia Laboratory Testing Market Outlook, by End User, 2020-2033
8.4.10. Nigeria Preeclampsia Laboratory Testing Market Outlook, by Test Type, 2020-2033
8.4.11. Nigeria Preeclampsia Laboratory Testing Market Outlook, by Preeclampsia Type, 2020-2033
8.4.12. Nigeria Preeclampsia Laboratory Testing Market Outlook, by End User, 2020-2033
8.4.13. Rest of Middle East Preeclampsia Laboratory Testing Market Outlook, by Test Type, 2020-2033
8.4.14. Rest of Middle East Preeclampsia Laboratory Testing Market Outlook, by Preeclampsia Type, 2020-2033
8.4.15. Rest of Middle East Preeclampsia Laboratory Testing Market Outlook, by End User, 2020-2033
8.5. BPS Analysis/Market Attractiveness Analysis
9. Competitive Landscape
9.1. Company Vs Segment Heatmap
9.2. Company Market Share Analysis, 2025
9.3. Competitive Dashboard
9.4. Company Profiles
9.4.1. DiabetOmics
9.4.1.1. Company Overview
9.4.1.2. Product Portfolio
9.4.1.3. Financial Overview
9.4.1.4. Business Strategies and Developments
9.4.2. DRG Instruments GmbH
9.4.3. Hoffmann-La Roche Ltd.
9.4.4. GestVision, Inc.
9.4.5. Lifeassay Diagnostics (Pty) Ltd.
9.4.6. Metabolomic Diagnostics
9.4.7. Perkin Elmer, Inc.
9.4.8. Progenity, Inc.
9.4.9. Quidel Corporation
9.4.10. Siemens Healthineers
10. Appendix
10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations